Pseudomonas methanica KY4634 was found to produce 5-lipoxygenase inhibitor designated KF8940, MY12-62a and MY12-62c. The inhibitors were purified by solvent extraction, silica gel column chromatography, reversed-phase low pressure liquid chromatography and crystallization. The chemical structures of KF8940, MY12-62a and MY12-62c were determined to be 2-n-heptyl-4-hydroxyquinoline-N-oxide, 2-n-heptyl-4-hydroxyquinoline and 3-n-heptyl-3-hydroxy-1,2,3,4-tetrahydroquinoline-2,4-diore, respectively, on the basis of their physico-chemical properties. Among them, KF8940 was the most potent inhibitor. The compound inhibited 5-lipoxygenase of rat basophilic leukemia cells in a dose-dependent manner and the half maximal inhibitory concentration (IC,0) was 1.5 x 10 M. At this concentration, KF8940 did not inhibit bovine platelet 12-lipoxygenase and cyclooxygenase, and the IC,,0 values for these enzyme were 3.5 x 10-5 M and 1.7 x 10-4 M, respectively. The results indicated that KF8940 is a potent and selective inhibitor of 5-lipoxygenase. The IC50 value of MY12-62c for 5-lipoxygenase was 1.9 x 10 M and that of MY12-62a was 1.9 x 10-5M.
culture broth and their structures were determined. Among them, KF8940, 2-n-heptyl-4-hydroxyquinoline-N-oxide, was a potent and selective inhibitor of the enzyme. This manuscript describes the fermentation, isolation and purification, structural identification, and some biological properties of the inhibitors. [5, 6, 8, 9, 11, 12, 14, 15 -3H]5-HETE (60.0 mCi/mmol) and [5,6,8,9,11,12,14,15-3H] thromboxane B2 (150 mCi/mmol) were obtained from New England Nuclear (Boston). 12-HETE was a generous gift from Dr. D. H. NUGTEREN (Uniliver Research Laboratorum Vlaardingen). Rat basophilic leukemia (RBL-1) cells [ATCC CRL1378] were obtained from the American Type Culture Collection (Rockville). Silica gel precoated TLC plate was obtained from E. Merck (Darmstadt).
All other reagents were of analytical grade.
Microorganism, Medium and Culture Conditions P. inethanica KY4634 was used in this study. The stock medium contained meat extract 1 %, peptone I%, NaCl 0.5 % and agar 2 %, pH 7.2. The seed medium contained glucose 2 %, peptone 1 %, yeast extract 1 % and NaCl 0.25 %, pH 7.4. The production medium contained glucose 1 %, glycerol 0.25 %, soybean meal 1 %, peptone 0.5 %, NaCl 0.3 %, KCl 0.03 %, MgSO4. 7H2O 0.05 % and CaCO3 0.3 %, pH 7.8. A slant culture grown on the stock medium was inoculated into a test tube (2.5 x 19 cm) containing 10 ml of the seed medium and incubated on a test tube shaker at 30°C for 24 hours. Twenty ml of the first seed culture was transferred to two 2-liter Erlenmeyer flasks containing 450 ml each of the seed medium. The flasks were incubated on a rotary shaker at 30°C for 24 hours (220 rpm). The content of the flasks was transferred into 18 liters of the fermentation medium in a 30-liter jar fermentor. The fermentation was performed for 4 to 6 days at 28°C by stirring at 180 rpm with aeration of 18 liters per minute.
Preparation of 5-Lipoxygenase RBL-1 cells were cultured in Eagle's minimal essential medium containing 20Y. fetal calf serum and 2 mm glutamine. Cells were maintained in flasks and grown in spinner culture for large scale production12). Cells were harvested by centrifugation at 400 x g for 10 minutes, washed once with phosphate buffered saline without calcium and magnesium, and then resuspended in the same buffer at 4 x 108 cells/ml. When stored at -80°C, the RBL-1 cell suspension retained 5-lipoxygenase activity for several month. The stored cell suspension was lysed by freeze-thawing before use. The frozenthawed homogenate or its 10,000 x g supernatant was used as the enzyme preparation of 5-lipoxygenase.
Measurement of 5-Lipoxygenase Activity
The reaction mixture of lipoxygenase contained 0.1 M Tris-HCl (pH 7.4), 1 mm reduced glutathione, 1 mm CaCl2 and 2 mm ATP13,11). The RBL-1 cell homogenate (2 x 107 cells/ml) or its 10,000 x g supernatant (3.6 mg protein/ml) was preincubated with test samples at 37°C for 5 minutes and then incubated with 30 µM [1-14C] arachidonic acid (1.6,uCi/ml) for 5 minutes. The reaction mixture was acidified with 0.2 M citric acid and the radioactive metabolites were extracted with EtOAc. The organic phase was evaporated under N2-gas stream. The residues were dissolved in EtOAc and applied to silica gel TLC. Petroleum ether -diethyl ether -AcOH (50: 50: 1) was used as developing solvent15). The radioactive product, [1-14C]5-HETE, was detected by autoradiography using [3H]5-HETE as an authentic sample, scraped off and counted in a liquid scintillation counter. In our assay system, the conversion rate from arachidonic acid to 5-HETE without inhibitors was approximately 7°
Measurement of 12-Lipoxygenase and Cyclooxygenase Activities 12-Lipoxygenase was prepared from bovine platelet cytosol by ammonium sulfate fraction according to the method of NUGTEREN18), and assay of the enzyme was performed as follows by the modified method of SIEGEL et al.1T). The reaction of 12-lipoxygenase was conducted in 0.1 M TrisHCl (pH 7.4), 2 mm reduced glutathione and 30 ,um [1-14C] arachidonic acid at 30°C for 10 minutes. The radioactive product, [1-14C]12-HETE, was isolated by TLC using ligroine -diethyl ether -AcOH (50: 50: 1) as developing solvent.
Bovine platelet microsome was used as cyclooxygenase by the method Of YOSHIMOTO et a1.18>.
The reaction was performed in 0.1 M Tris-HCl (pH 7.4), 5 MM L-tryptophan, 2 ,um hemoglobin and 30 µM [1-14C] arachidonic acid at 30°C for 10 minutes. The radioactive thromboxane B2, a cyclooxygenase metabolite in this system, was isolated by TLC developed with petroleum ether -diethyl etherAcOH (15: 85: 0.1). The extraction, detection and quantification procedures of each radioactive product were the same as described in the 5-lipoxygenase assay.
Results
Production of Inhibitor by P. methanica KY4634 A typical time course of the production in a 30-liter jar fermentor is shown in Fig. 1 . The inhibitory activity reached its maximum on the 5th day and then gradually decreased.
Isolation and Characterization of the Inhibitors
The inhibitors were isolated from the fermentation broth by the following procedures (Fig. 2) .
The filtered broth (18 liters) was acidified with HCl to pH 2.0 and extracted twice with 18 liters of ethyl acetate. The extract was evaporated in vacuo to remove ethyl acetate. The remained aqueous phase was adsorbed to 1 liter of Diaion HP-20 and eluted with methanol. The eluate was concentrated in vacuo and the resulting oily residue was applied to silica gel (Wako gel C-200) column (5.0 x 50 cm).
Chromatography was performed with chloroform -methanol (9: 1). Inhibitory activities were separated into two fractions (F-1 and F-2) and each fraction was concentrated to dryness in vacuo. KF8940 and MY12-62c were obtained from the F-2 fraction as follows. The F-2 was dissolved in minimal volume of 80Y. methanol and applied to reversed-phase low pressure liquid chromatography, Lobar RP-8 type B (Merck), using 80% methanol as a mobile phase. Activities were separated into two fractions. KF8940 was contained in the former fraction (F-2a) and MY12-62c was con- The production of inhibitors was monitored by measuring the percent inhibition of 5-lipoxygenase as described under "Materials and Methods", where the broth supernatant was added at 5 volume of the reaction mixture. The frozenthawed homogenate of RBL-1 cells was used as 5 C-2 C-3 (4.6 x 280 mm, Nagel) using 60 % acetonitril as a mobile phase (Fig. 3) .
Structure Elucidation of KF8940, MY12-62a
and MY12-62c These data indicated that KF8940, MY 12-62c and MY12-62a were 2-n-heptyl-4-hydroxyquinoline-N-oxide, 2-n-heptyl-4-hydroxyquinoline and 3-n-heptyl-3-hydroxy-1,2,3,4-tetrahydroquinoline-2,4-dione, respectively (Fig. 4) . These structures were confirmed by comparing with spectra of authentic compounds.
2-n-Heptyl-4-hydroxyquinoline-N-oxide and 2-n-heptyl-4-hydroxyquinoline were isolated by HAYS et a1.10) as antibiotic substances from Pseudomonas aeruginosa. Afterward LIGETBOWN and JACKSON20 21)
revealed that 2-n-heptyl-4-hydroxyquinoline-N-oxide was an antagonist of dihydrostreptomycin and an inhibitor of electron transport through the cytochrome b-c1 segment of the respiratory chain.
3-n-Heptyl-3-hydroxy-1,2,3,4-tetrahydroquinoline-2,4-dione was isolated by NEUENHAUx et a1. 22) as a metabolite of P. aeruginosa. However, no reports that these compounds possess lipoxygenase inhibitory activities have been described so far.
Biochemical Properties of KF8940
As shown in The IC50 values for 12-lipoxygenase and cyclooxygenase were 3.5 x 10-5 M and 1.7 x 10-4 M, respectively (Fig. 5 ). These data indicated that KF8940 is a potent and selective inhibitor of 5-lipoxygenase.
Biochemical Properties of MY12-62c and MY12-62a
Other 5-lipoxygenase inhibitors from P. inethanica KY4634, MY12-62c and MY12-62a, were examined on their selectivity and potency. The IC50 values of the compounds for 5-and 12-lipoxygenase, and cyclooxygenase are listed in Table 2 . Although the inhibitory activity of MY12-62c against 5-lipoxygenase was much less potent than that of KF8940, the compound selectively inhibited 
Discussion
A number of 5-lipoxygenase inhibitors have recently been found from synthetic compounds and herb medicine components. However, no microbial metabolites have been reported to inhibit 5-lipoxygenase. Now, we have found that P. methanica KY4634 produced potent inhibitors of 5-lipoxygenase. From the culture broth, three 5-lipoxygenase inhibitors were isolated. Among them, KF8940, 2-nheptyl-4-hydroxyquinoline-N-oxide, was a potent and selective inhibitor of 5-lipoxygenase.
Most compounds reported to inhibit 5-lipoxygenase inhibited 12-lipoxygenase or cyclooxygenase simultaneously. There have been only several 5-lipoxygenase inhibitors without cyclooxygenase and 12-lipoxygenase inhibition. The representative 5-lipoxygenase inhibitors and their inhibitory profiles together with those of KF8940 are listed in Table 2 . Comparing the inhibitors so far reported, KF8940 may be one of the most potent and selective 5-lipoxygenase inhibitors; IC50 was 1.5 X 10-7 M and its selectivity ratio (IC50 for 12-lipoxygenase/IC50 for 5-lipoxygenase) was 233. As for the selectivity, it will be further required to examine the effeet on other lipoxygenases, particularly mammalian 15-lipoxygenase, and we are now investigating this subject. More precise biochemical and pharmacological properties of the compound will be reported in succeeding papers of this series.
